SYS-CON MEDIA Authors: Lori MacVittie, RealWire News Distribution, Cynthia Dunlop, Mark O'Neill, Kevin Benedict

News Feed Item

PeriGen Launches Web-Based Tool, Category II Management Algorithm at SMFM Annual Meeting

Complimentary App Supports Management of Patients During Fetal Heart Rate Category II

CRANBURY, NJ -- (Marketwired) -- 02/04/14 -- PeriGen, the global leader in providing evidence-based perinatal system solutions with real-time clinical decision support, today announced the launch of its new web-based tool, Category II Management Algorithm. The online tool is based on a recent publication by noted clinical experts and is intended to support the management of patients during FHR category II -- which affects more than 80 percent of labors.

The free app, available at www.perigen.com and accessed via mobile devices such as smartphones and tablets as well as PCs, is being launched this week at PeriGen Booth 704 during the Society for Maternal-Fetal Medicine (SMFM) 34th Annual Meeting at the Hilton New Orleans Riverside in New Orleans.

The app is based on the article "Intrapartum Management of Category II Fetal Heart Rate Tracings: Towards Standardization of Care" published in the August 2013 edition of the American Journal of Obstetrics and Gynecology. The article's authors are OB experts including PeriGen Chief Medical Officer Thomas J. Garite, M.D. By answering a few questions about the tracing and labor status, the application will process this information through the algorithm and present its conclusions. Users can get to the suggested outcome in seconds within four to eight clicks.

"More than 80 percent of patients in labor spend time in the FHR Category II," said PeriGen CEO Matthew Sappern. "The impressive body of research that has expanded over the years and resulted in this publication reflects the work of few that truly touches many. PeriGen is pleased to support the authors by extending real-time access to all of this remarkable work to clinicians."

PeriGen will demonstrate its PeriCALM® fetal surveillance solutions and the new Category II Management Algorithm app in Booth 704 at the SMFM annual meeting.

PeriGen also has a strong event presence in post-graduate and poster presentations. Dr. Garite is co-director of the full-day post-graduate courses titled "Electronic Fetal Monitoring 2014: Where Are We?" on Feb. 4. His co-director is Sean C. Blackwell, M.D., Department of Obstetrics, Gynecology and Reproductive Sciences, UT Health-University of Texas Medical School at Houston.

Emily Hamilton, MDCM, FRCSC, FACOG, PeriGen's senior vice president of clinical research, will present:

  • A post-graduate course on "Current State of Computerized FHR Interpretation" on Feb. 4 from 1:40 to 2:20 p.m., CST and
  • A poster presentation on "Baseline Variability in Normal Term Births and in Births Complicated by Neonatal Depression" on Feb. 7 from 3:30 to 5:30 p.m. CST.

About PeriGen, Inc.
PeriGen, Inc., is an innovative provider of fetal surveillance systems employing patented, pattern-recognition and obstetrics technologies that empower perinatal clinicians to make confident, real-time decisions about the mothers and babies in their care. PeriGen's customer-centric team of clinicians and technologists builds the most advanced systems available to augment obstetric decision-making and improve communications among the clinical team at the point of care, while supporting data flow between healthcare IT systems. PeriGen is a KLAS® recognized leader in the obstetrics/perinatal space and offers the only EFM pattern recognition system that is validated by the NICHD. For more information, please visit us at www.PeriGen.com.

Add to Digg Bookmark with del.icio.us Add to Newsvine

Media Contact:
Angela Jenkins
Amendola Communications for PeriGen
720.859.6930
Email Contact

PeriGen Contact:
Suzanne Trajkoski
Marketing Director
609.228.8346
Email Contact

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.